🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
Varicose veins are enlarged, noticeably bulging veins, which commonly occur...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01231373
The purpose of this study is to demonstrate superiority of Nepafenac Ophtha...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01853072
Treatments Being Tested
The purpose of this study was to determine if difluprednate ophthalmic emul...
Status
Completed
Location
Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
Start Date
2011-02
Trial ID
NCT01276223
Treatments Being Tested
This study was to compare the safety and efficacy of the preservative-free ...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-06
Trial ID
NCT01026831
Treatments Being Tested
The objective of this study was to compare the safety, efficacy, and tolera...
Status
Completed
Location
CYS-002 Investigational Site
Start Date
2016-01
Trial ID
NCT02617667
Treatments Being Tested
This is a multicentre, randomised, double-masked, parallel-group, phase IV ...
Status
Completed
Location
Kharkov District Clinical Hospital
Start Date
2009-02
Trial ID
NCT01357538
Treatments Being Tested
This is a Phase III multi-center, double-masked, vehicle-controlled, random...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02492321
Treatments Being Tested
Study to evaluate the safety and tolerability of MC-1101, a potential topic...
Status
Completed
Location
Sall Eye Center
Start Date
2013-09
Trial ID
NCT01922128
Treatments Being Tested
Safety and tolerability of three different concentrations (0.1%, 03%, 0.6%)...
Status
Completed
Location
Central Contact
Start Date
2017-05-10
Trial ID
NCT03131167
Treatments Being Tested